{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de073-e127-72a6-a95e-e417b3ed6013",
  "slug": "0a46c3e8bf46013b57087adaac7a88f4",
  "title": "Xeris Biopharma | Investor Presentation Deck | 11 slides",
  "subtitle": "Xeris Biopharma · 2022-10",
  "author": "Xeris Biopharma",
  "date": "2022-10-01 00:00:00",
  "pageCount": 11,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de073-e127-72a6-a95e-e417b3ed6013",
    "slug": "0a46c3e8bf46013b57087adaac7a88f4",
    "title": "Xeris Biopharma | Investor Presentation Deck | 11 slides",
    "rawTitle": "Xeris Biopharma | Investor Presentation Deck | 11 slides",
    "authorId": "xeris-biopharma",
    "authorName": "Xeris Biopharma",
    "authorDisplay": "Xeris Biopharma",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2022-10__xeris-biopharma__investor-pres__0a46c3e8.pdf",
    "sourceUrl": "https://www.slidebook.io/company/xeris-biopharma/presentation/0a46c3e8bf46013b57087adaac7a88f4/",
    "sourceDate": null,
    "presentationDate": "2022-10-01 00:00:00",
    "ingestedAt": "2026-04-30 22:13:04.013709+00",
    "status": "ready",
    "pageCount": 11,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2022-10__xeris-biopharma__investor-pres__0a46c3e8",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 11,
    "pagesIndexed": 11,
    "pagesWithImages": 11,
    "pagesWithMetadata": 11,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 44,
    "chartCount": 3,
    "metricSlides": 0,
    "toolMatches": 5,
    "documentToolMatches": 0,
    "frameworkMatches": 2,
    "arcMatches": 1,
    "beatMatches": 5,
    "loopMatches": 2,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "evidence": "The deck follows a structure similar to the Sequoia Pitch, with sections on market size, product, solution, and team.",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:25:26.012641+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 4,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 4,
        "name": "Problem",
        "beatId": "1cb39058-49a4-4f20-ad7f-4e5ca72f0e60",
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "beatType": {
          "name": "Problem",
          "slug": "sequoia-pitch-problem",
          "status": "active",
          "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
          "version": 1,
          "description": null
        },
        "evidence": "The market sizing slide presents the problem and opportunity.",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 6,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 5,
        "name": "Product",
        "beatId": "af072837-2b90-4168-8f35-e24f021b1e1f",
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "beatType": {
          "name": "Product",
          "slug": "sequoia-pitch-product",
          "status": "active",
          "canonId": "019dd9b8-2259-77df-a937-8b665c8066fe",
          "version": 1,
          "description": null
        },
        "evidence": "The appendix methodology slides describe the product and study design.",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 8,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 7,
        "name": "Solution",
        "beatId": "618cb87d-97ad-4b2e-bac2-934e0c49b76f",
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "beatType": {
          "name": "Solution",
          "slug": "sequoia-pitch-solution",
          "status": "active",
          "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
          "version": 1,
          "description": null
        },
        "evidence": "The traction and appendix methodology slides present the solution and clinical results.",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Turn",
          "slug": "turn",
          "status": "active",
          "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
          "version": 1,
          "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": null,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": null,
        "name": "Financials",
        "beatId": "8c33858e-388a-4635-945e-637cef7dc824",
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "beatType": {
          "name": "Financials",
          "slug": "sequoia-pitch-financials",
          "status": "active",
          "canonId": "019dd9b8-245d-74ce-8a5e-8094ec926a75",
          "version": 1,
          "description": null
        },
        "evidence": null,
        "position": 3,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 10,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 10,
        "name": "Key Takeaways",
        "beatId": "66138fc9-0919-4404-8cc7-48babd267bd8",
        "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
        "beatType": null,
        "evidence": "The key takeaways slide summarizes the main points.",
        "position": 4,
        "isPrimaryArc": true,
        "parentBeatType": null,
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 4,
        "from": 4,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "bc2291b6-982f-4de3-9315-7a84eb9dc296",
        "evidence": "The market sizing slide implies the cost of inaction.",
        "position": 0,
        "objective": "What are the limitations of current Levothyroxine therapies?",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 03:25:26.217771+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 10,
        "from": 5,
        "loop": {
          "name": "11_golden_circle",
          "slug": "11-golden-circle",
          "status": "active",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
          "familyLabel": null,
          "categoryName": "Vision",
          "categorySlug": "vision"
        },
        "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
        "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
        "position": 1,
        "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:25:26.250383+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Slide recipe: Cover",
          "slug": "cover-slide",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
          "version": 1,
          "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
          "description": "The first ten seconds. Build it deliberately.",
          "familyLabel": "slide-recipe",
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "designer",
        "layer": "slide",
        "agents": [
          "designer"
        ],
        "matchId": "2ac3816c-47a6-44b4-8af1-1227344f1e22",
        "evidence": "The slide features a clear title, company name, and logo, indicating a standard cover slide.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:14:20.904704+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Market Segmentation Pyramid",
          "slug": "market-segmentation-pyramid",
          "status": "active",
          "bestFor": null,
          "canonId": "1c9f3543-c96f-4a5b-b4a4-9b2a412c0aaf",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "631d0e42-5cea-4e04-ab4a-dd7c591d5d1e",
        "evidence": "list/bullet: 105M Rx/yr dispensed; 47% GI condition; 21% concomitant meds; 17% compliance issues; 15% hard to control; 62M weekly doses; $30-$50/dose; $2-3B Opportunity",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-17 03:36:32.178779+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Executive summary",
          "slug": "executive-summary",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
          "version": 1,
          "bodyDocId": null,
          "description": "A condensed view of the entire argument on a single slide / block.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "62ad1468-8377-4585-b87a-28092f94db55",
        "evidence": "list/bullet: Study Objectives: Characterize pharmacokinetics; Evaluate dose proportionality; Assess safety and tolerability.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:36:32.250501+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "a4aa124e-0245-4bc2-9866-23fede544890",
        "evidence": "chart/line: Pharmacokinetic profile comparing XP-8121 SC and Synthroid PO over 28 days.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:36:32.353796+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 7,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "SCQA Framework",
          "slug": "scqa-framework",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7bcb-763f-bdf6-1dfedf3bd36c",
          "version": 1,
          "bodyDocId": "019df22a-a0b0-719e-937e-2ac31e53d32c",
          "description": "Situation, Complication, Question, Answer - structured problem framing",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "e02c3edf-33c7-4850-a49e-a4b49c03c3ec",
        "evidence": "list/bullet: All data from XP-8121-108 combined to generate PopPK model.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:36:32.454603+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "1d18db4f-b668-4608-9afe-149137e5367a",
        "evidence": "Quantifies total addressable market and specific segments based on clinical pain points.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 12:21:14.465+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "frameworkName": "market-sizing"
      },
      {
        "matchId": "df4bd889-a94b-4b4b-85ae-49ccb42bac87",
        "evidence": "Visual representation of study arms, periods, and washout intervals.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 12:21:13.195+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "frameworkName": "clinical-trial-design"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "title": "Includes Exhibit 99.2 reference and copyright notice.",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/LFKhL1ckq69yThL4Z2TGRMAr1bzGm3DRR--raxnol2w/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wYTQ2YzNlOGJmNDYwMTNiNTcwODdhZGFhYzdhODhmNC9wMDAxLmpwZw",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 51,
        "componentCount": 6,
        "textChars": 323,
        "nDataPoints": 0,
        "notes": "Includes Exhibit 99.2 reference and copyright notice.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:12.462+00",
          "seconds": 2.921,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/1",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-1",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.04,
            "y": 0.96
          },
          "kind": "disclaimer",
          "text": "Copyright ©2017-2022 Xeris Biopharma Holdings. All rights reserved.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fbb12a9-5393-4c4f-826e-e6331eb01463",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.04,
            "y": 0.08
          },
          "kind": "image",
          "text": "Xeris Biopharma logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a215a13-5033-484e-b08d-9ed31eb54260",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 1,
            "w": 0.55,
            "x": 0.45,
            "y": 0
          },
          "kind": "image",
          "text": "Scientist looking at a test tube",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f43abe2-faa3-484f-8981-6d32c3a35574",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.04,
            "y": 0.42
          },
          "kind": "paragraph",
          "text": "A growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65723fbd-1fad-43db-8b17-30d184f0b3b1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.08,
            "x": 0.88,
            "y": 0.02
          },
          "kind": "source-note",
          "text": "Exhibit 99.2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d8485538-3744-4eae-b760-fdc8967d8d8e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.35,
            "x": 0.04,
            "y": 0.17
          },
          "kind": "title",
          "text": "Xeris Biopharma (Nasdaq: XERS)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d38a3a61-2a08-4556-b115-bf6086c3d221",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Slide recipe: Cover",
            "slug": "cover-slide",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3",
            "version": 1,
            "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65",
            "description": "The first ten seconds. Build it deliberately.",
            "familyLabel": "slide-recipe",
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "designer",
          "layer": "slide",
          "agents": [
            "designer"
          ],
          "matchId": "2ac3816c-47a6-44b4-8af1-1227344f1e22",
          "evidence": "The slide features a clear title, company name, and logo, indicating a standard cover slide.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:14:20.904704+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/HfIhtuAlpZRCt55m_zb2V6F-IhVtCgG7bp8muvzZZSg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wYTQ2YzNlOGJmNDYwMTNiNTcwODdhZGFhYzdhODhmNC9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/t2hK3jkktWI7MYPqURGdW7gSTQfBGcLB6GiAAD7Cpc8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wYTQ2YzNlOGJmNDYwMTNiNTcwODdhZGFhYzdhODhmNC9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/HLNuZR6LYiIVgeER1N75nkRKzc7qWx67_CUJw4PeDSU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wYTQ2YzNlOGJmNDYwMTNiNTcwODdhZGFhYzdhODhmNC9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "front_matter",
      "rawType": "agenda",
      "block": null,
      "metadata": {
        "slideType": "agenda",
        "slideTypeCanon": {
          "name": "Agenda",
          "slug": "agenda",
          "status": "active",
          "canonId": "019de52d-061b-7470-b138-3ffa5e612cce",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 5,
        "textChars": 277,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:13.048+00",
          "seconds": 3.009,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/2",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-2",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.25,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "disclaimer",
          "text": "Copyright ©2017-2022 Xeris Pharmaceuticals, Inc. All rights reserved.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.048+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "69ceb423-93ff-40dc-be9e-029b16df48cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.15,
            "x": 0.05,
            "y": 0.8
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.048+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fca8b79-5fd4-44b2-ab43-d99f21777476",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 1,
            "w": 0.5,
            "x": 0.5,
            "y": 0
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.048+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "840d5d15-1664-442b-af6e-baecbc8c4c72",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.4,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "list",
          "text": "Agenda\nOpening Remarks: Paul Edick, Chairman and CEO\nStudy Results: Ken Johnson, PharmD\nSVP, Global Development and Medical Affairs\nQ&A",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.048+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dcc4ce37-33f1-4dbb-a4fb-b603238b38c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.4,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "title",
          "text": "Topline Results of Phase 1 Study of Levothyroxine: PO vs SC (XP-8121-108)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.048+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "140bf575-e021-4054-b73c-7944491943fe",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "setup",
      "function": "other",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 3,
        "textChars": 3064,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:18.194+00",
          "seconds": 7.963,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/3",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-3",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.91,
            "x": 0.045,
            "y": 0.24
          },
          "kind": "disclaimer",
          "text": "Any statements in this presentation about future expectations, plans and prospects for Xeris Biopharma Holdings, Inc., including the development of a sub-cutaneous formulation of levothyroxine, the market and therapeutic potential of Xeris' products and product candidates, expectations regarding clinical data or results from planned clinical trials, the timing of clinical trials, the timing or likelihood of regulatory approval and commercialization of its product candidates, the timing or likelihood of expansion of current marketed products into new indications and uses or into additional markets, the potential utility of its proprietary formulation technology platforms, and other statements containing the words \"expected,\" \"will,\" \"would,\" \"continue,\" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on numerous assumptions and assessments made in light of Xeris' experience and perception of historical trends, current conditions, business strategies, operating environment, future developments, and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Various factors could cause Xeris' actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements, including the impact of COVID-19 on our business operations and clinical activities, our ability to fund our product development programs or commercialization efforts, whether our clinical trials demonstrate efficacy and safety to the satisfaction of the FDA or other regulatory authorities, and whether our products will achieve and maintain market acceptance. No assurance can be given that our expectations will be realized and persons reading this communication are, therefore, cautioned not to place undue reliance on these forward-looking statements. Additional information about economic, competitive, governmental, technological, and other factors that may affect Xeris is set forth in the \"Risk Factors\" section of the most recently filed Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission, the contents of which are not incorporated by reference into, nor do they form a part of, this communication. Forward-looking statements in this communication are based upon information available to Xeris, as of the date of this communication and, while believed to be reasonable, actual results may differ materially. Subject to any obligations under applicable law, Xeris does not undertake any obligation to update any forward-looking statement whether as a result of new information, future developments or otherwise, or to conform any forward-looking statement to actual results, future events, or to changes in expectations.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:18.194+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbbe8090-2f4a-437b-9114-dc37444c1471",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.08,
            "x": 0.88,
            "y": 0.92
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:18.194+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ebd247f-ce7e-4eec-9995-43c6cae49847",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.375,
            "x": 0.045,
            "y": 0.135
          },
          "kind": "title",
          "text": "Forward-looking statements",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:18.194+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "60461e4e-c8fc-420c-96e5-94e6d3498222",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "resolution",
      "title": "The slide uses a problem-solution framework to justify the market size for a new delivery method.",
      "function": "size_opportunity",
      "rawType": "market_sizing",
      "block": null,
      "metadata": {
        "slideType": "market_sizing",
        "slideTypeCanon": {
          "name": "Market sizing",
          "slug": "market_sizing",
          "status": "active",
          "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b",
          "version": 1,
          "description": null
        },
        "function": "size_opportunity",
        "functionCanon": {
          "name": "Size opportunity",
          "slug": "size_opportunity",
          "status": "active",
          "canonId": "019de52d-147b-7568-8828-a74a27697618",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 6,
        "textChars": 837,
        "nDataPoints": 7,
        "notes": "The slide uses a problem-solution framework to justify the market size for a new delivery method.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:14.465+00",
          "seconds": 3.945,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/4",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-4",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.4,
            "x": 0.55,
            "y": 0.31
          },
          "kind": "list",
          "text": "105M Rx/yr dispensed; 47% GI condition; 21% concomitant meds; 17% compliance issues; 15% hard to control; 62M weekly doses; $30-$50/dose; $2-3B Opportunity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "60bbddbd-0b25-4a58-968f-6caedee633e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.04,
            "y": 0.45
          },
          "kind": "list",
          "text": "1st injectable levothyroxine indicated for hypothyroidism; Bypasses GI tract; Improved regimen compliance; Demonstrate safety; Small volume, ready-to-use",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fd86a93-3356-4bae-97d3-814afae84507",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.04,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "XP-8121 — Levothyroxine. For maintenance therapy in patients with congenital or acquired hypothyroidism who require thyroid hormone replacement",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "115ef5e5-86a8-4510-9801-d0ce71d24440",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.04,
            "y": 0.88
          },
          "kind": "source-note",
          "text": "Sources: 1. IQVIA NPA Y2021; 2. McMillan M et al. Drugs R D. 2016 16(1):53-68; 3. Robertson HM et al Thyroid : Official Journal of the American Thyroid Association. 2014 24(12):1765-1771. 4. Tirosint WAC and 5x premium to Synthroid",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34d8bd06-453a-4e34-a6f0-e1a669b4636b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.92,
            "x": 0.04,
            "y": 0.21
          },
          "kind": "title",
          "text": "With over 100M Rx/yr, oral levothyroxine is one of the most prescribed therapies in US",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e34fe21d-59f8-4eef-84ea-3605e171d66b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.92,
            "x": 0.04,
            "y": 0.12
          },
          "kind": "title",
          "text": "XeriSol™ Levothyroxine may enable 1x/weekly subcutaneous (SC) therapy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "842f6723-afa8-4932-b73e-e40675387b34",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Market Segmentation Pyramid",
            "slug": "market-segmentation-pyramid",
            "status": "active",
            "bestFor": null,
            "canonId": "1c9f3543-c96f-4a5b-b4a4-9b2a412c0aaf",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "631d0e42-5cea-4e04-ab4a-dd7c591d5d1e",
          "evidence": "list/bullet: 105M Rx/yr dispensed; 47% GI condition; 21% concomitant meds; 17% compliance issues; 15% hard to control; 62M weekly doses; $30-$50/dose; $2-3B Opportunity",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:36:32.178779+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "1d18db4f-b668-4608-9afe-149137e5367a",
          "evidence": "Quantifies total addressable market and specific segments based on clinical pain points.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 12:21:14.465+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "frameworkName": "market-sizing"
        }
      ],
      "arcBeats": [
        {
          "to": 4,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 4,
          "name": "Problem",
          "beatId": "1cb39058-49a4-4f20-ad7f-4e5ca72f0e60",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The market sizing slide presents the problem and opportunity.",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 4,
          "from": 4,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "bc2291b6-982f-4de3-9315-7a84eb9dc296",
          "evidence": "The market sizing slide implies the cost of inaction.",
          "position": 0,
          "objective": "What are the limitations of current Levothyroxine therapies?",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-17 03:25:26.217771+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 5,
      "type": "resolution",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 36,
        "componentCount": 4,
        "textChars": 342,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:12.739+00",
          "seconds": 2.191,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/5",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-5",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.045,
            "y": 0.24
          },
          "kind": "list",
          "text": "Background: Reliance on FDA findings for Synthroid; Single 600 ug dose comparison; Three ascending doses of XP-8121 SC.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.739+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16a7f1fe-0a1d-476c-861b-f388f79b6062",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.045,
            "y": 0.66
          },
          "kind": "list",
          "text": "Chronic Dosing Simulations: Compare steady state exposure; Determine dose conversion.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.739+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "925b0cf8-ee29-423c-bd7c-e8a89872c75f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.045,
            "y": 0.45
          },
          "kind": "list",
          "text": "Study Objectives: Characterize pharmacokinetics; Evaluate dose proportionality; Assess safety and tolerability.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.739+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9b5bf4df-c5d8-466a-b16e-e94e84d36bd0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.39,
            "x": 0.045,
            "y": 0.12
          },
          "kind": "title",
          "text": "XP-8121-108: Study Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.739+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "43106cd0-a9d7-4c64-8d0d-fc3861a0aaa7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Executive summary",
            "slug": "executive-summary",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
            "version": 1,
            "bodyDocId": null,
            "description": "A condensed view of the entire argument on a single slide / block.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "62ad1468-8377-4585-b87a-28092f94db55",
          "evidence": "list/bullet: Study Objectives: Characterize pharmacokinetics; Evaluate dose proportionality; Assess safety and tolerability.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:36:32.250501+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 6,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Product",
          "beatId": "af072837-2b90-4168-8f35-e24f021b1e1f",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": {
            "name": "Product",
            "slug": "sequoia-pitch-product",
            "status": "active",
            "canonId": "019dd9b8-2259-77df-a937-8b665c8066fe",
            "version": 1,
            "description": null
          },
          "evidence": "The appendix methodology slides describe the product and study design.",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 6,
      "type": "resolution",
      "title": "The slide outlines a clinical trial structure involving two parts, with crossover periods for Part 1.",
      "function": "plan_implementation",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 41,
        "componentCount": 4,
        "textChars": 303,
        "nDataPoints": 6,
        "notes": "The slide outlines a clinical trial structure involving two parts, with crossover periods for Part 1.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:13.195+00",
          "seconds": 2.583,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/6",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-6",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "diagram",
          "text": "Study flow diagram showing Part 1 (crossover) and Part 2 (parallel) arms with specific dosages and group sizes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.195+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2ffbabd-57cf-412e-8f16-70a5486be859",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.08,
            "y": 0.8
          },
          "kind": "list",
          "text": "Mean Concentration Profile Over Time\nKey PK Parameters - Cmax, Tmax, AUCs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.195+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7d41c91-fc38-4548-b4eb-0df058c54c03",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.6,
            "x": 0.05,
            "y": 0.74
          },
          "kind": "paragraph",
          "text": "PK results based on Baseline-Adjusted T4 Concentrations to determine:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.195+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07f7b0f2-a218-403e-98b9-a117b481b4c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.05,
            "y": 0.08
          },
          "kind": "title",
          "text": "Phase 1 Pharmacokinetic Study Design (XP-8121-108)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.195+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16898e13-2284-4212-86ca-300d4515d430",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "df4bd889-a94b-4b4b-85ae-49ccb42bac87",
          "evidence": "Visual representation of study arms, periods, and washout intervals.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 12:21:13.195+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "frameworkName": "clinical-trial-design"
        }
      ],
      "arcBeats": [
        {
          "to": 6,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 5,
          "name": "Product",
          "beatId": "af072837-2b90-4168-8f35-e24f021b1e1f",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": {
            "name": "Product",
            "slug": "sequoia-pitch-product",
            "status": "active",
            "canonId": "019dd9b8-2259-77df-a937-8b665c8066fe",
            "version": 1,
            "description": null
          },
          "evidence": "The appendix methodology slides describe the product and study design.",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 7,
      "type": "analysis",
      "title": "The chart compares subcutaneous (SC) administration of XP-8121 against oral (PO) administration of Synthroid.",
      "function": "analyze_data",
      "rawType": "appendix_data",
      "block": null,
      "metadata": {
        "slideType": "appendix_data",
        "slideTypeCanon": {
          "name": "Appendix data",
          "slug": "appendix_data",
          "status": "active",
          "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 39,
        "componentCount": 3,
        "textChars": 461,
        "nDataPoints": 2,
        "notes": "The chart compares subcutaneous (SC) administration of XP-8121 against oral (PO) administration of Synthroid.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:17.895+00",
          "seconds": 7.236,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/7",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-7",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.6,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "chart",
          "text": "Pharmacokinetic profile comparing XP-8121 SC and Synthroid PO over 28 days.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:17.895+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9441c3b4-686e-417d-b3e9-d6cd74300eff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.65,
            "y": 0.2
          },
          "kind": "list",
          "text": "Synthroid PO 600 ug exhibits a rapid rise in levothyroxine levels followed by a rapid decline. XP-8121 SC exhibits a lower maximum concentration (Cmax), longer time to maximum concentration (Tmax) with sustained exposure profile relative to Synthroid PO administration.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:17.895+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d901d92-dc1a-41ff-8abe-96ebdc8ad0e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Baseline Adjusted T4 Concentration by Time Profile Day 1 to Day 28 Following Single Dose Administration (XP-8121-108)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:17.895+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a259bd9-723a-43f9-aaaf-4c5dc8cc0e8e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "a4aa124e-0245-4bc2-9866-23fede544890",
          "evidence": "chart/line: Pharmacokinetic profile comparing XP-8121 SC and Synthroid PO over 28 days.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:36:32.353796+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 7,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Solution",
          "beatId": "618cb87d-97ad-4b2e-bac2-934e0c49b76f",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The traction and appendix methodology slides present the solution and clinical results.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 8,
      "type": "evidence",
      "title": "Clinical trial data (XP-8121-108) comparing subcutaneous (SC) vs oral (PO) administration.",
      "function": "analyze_data",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 45,
        "componentCount": 3,
        "textChars": 598,
        "nDataPoints": 4,
        "notes": "Clinical trial data (XP-8121-108) comparing subcutaneous (SC) vs oral (PO) administration.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:13.083+00",
          "seconds": 2.364,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/8",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-8",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.68,
            "w": 0.62,
            "x": 0.05,
            "y": 0.21
          },
          "kind": "chart",
          "text": "Line chart showing T4 concentration over 28 days for different doses of XP-8121 and Synthroid.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56e25a95-a2ed-423f-b3f9-85e898c47d4b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.68,
            "w": 0.3,
            "x": 0.67,
            "y": 0.21
          },
          "kind": "list",
          "text": "Synthroid PO 600 ug exhibits a rapid rise in levothyroxine levels followed by a rapid decline. XP-8121 SC exhibits a lower maximum concentration (Cmax), longer time to maximum concentration (Tmax) with sustained exposure profile relative to Synthroid PO administration. Confirmation of dose proportional exposure with ascending doses of XP-8121. No major safety concerns were identified.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d3157f3a-1344-4f7f-9131-9043f290c443",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.92,
            "x": 0.04,
            "y": 0.04
          },
          "kind": "title",
          "text": "Baseline Adjusted T4 Concentration by Time Profile Day 1 to Day 28 Following Single Dose Administration (XP-8121-108)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f65367ad-dc8a-4d14-9813-9f4d52800471",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Solution",
          "beatId": "618cb87d-97ad-4b2e-bac2-934e0c49b76f",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The traction and appendix methodology slides present the solution and clinical results.",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 9,
      "type": "analysis",
      "title": "The chart shows a comparison of simulated thyroxine concentrations over 7 days.",
      "function": "analyze_data",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 44,
        "componentCount": 4,
        "textChars": 368,
        "nDataPoints": 4,
        "notes": "The chart shows a comparison of simulated thyroxine concentrations over 7 days.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:13.902+00",
          "seconds": 3.089,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/9",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-9",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.48,
            "x": 0.04,
            "y": 0.3
          },
          "kind": "chart",
          "text": "Pharmacokinetic simulation chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.902+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6b0cadc4-a711-4a57-935d-8a0eb0908e1d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.42,
            "x": 0.55,
            "y": 0.3
          },
          "kind": "list",
          "text": "All data from XP-8121-108 combined to generate PopPK model. Simulated pharmacokinetic profile to estimate exposure. Implies 1200 ug once-weekly XP-8121 SC provides similar exposure to Synthroid PO 300 ug/day.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.902+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94365476-cad5-485a-b4c5-d2952cda3433",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.92,
            "x": 0.04,
            "y": 0.22
          },
          "kind": "title",
          "text": "XP-8121 SC 1200 µg/week has similar exposure to Synthroid PO 300 µg/day at steady state",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.902+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9293b7c2-b23b-47ef-b599-be65d6221b61",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.45,
            "x": 0.04,
            "y": 0.12
          },
          "kind": "title",
          "text": "PopPK Model: Simulation of Chronic Dosing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.902+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63d49785-0e50-4ec3-ac26-6f6ad80ad2e4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "SCQA Framework",
            "slug": "scqa-framework",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7bcb-763f-bdf6-1dfedf3bd36c",
            "version": 1,
            "bodyDocId": "019df22a-a0b0-719e-937e-2ac31e53d32c",
            "description": "Situation, Complication, Question, Answer - structured problem framing",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "e02c3edf-33c7-4850-a49e-a4b49c03c3ec",
          "evidence": "list/bullet: All data from XP-8121-108 combined to generate PopPK model.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:36:32.454603+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 10,
      "type": "resolution",
      "function": "summarize",
      "rawType": "key_takeaways",
      "block": null,
      "metadata": {
        "slideType": "key_takeaways",
        "slideTypeCanon": {
          "name": "Key takeaways",
          "slug": "key_takeaways",
          "status": "active",
          "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 42,
        "componentCount": 2,
        "textChars": 707,
        "nDataPoints": 2,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:12.945+00",
          "seconds": 2.035,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/10",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-10",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.91,
            "x": 0.045,
            "y": 0.25
          },
          "kind": "list",
          "text": "Large market opportunity: Oral levothyroxine is one of the most prescribed therapies in US with over 100 million prescriptions annually\nDemonstrated proof-of-concept: A once weekly subcutaneous injection of XP-8121 can provide comparable exposure to daily oral Synthroid® supporting further development in patients with congenital or acquired hypothyroidism who require thyroid hormone replacement\nDose conversion ratio established: Chronic dosing simulation implies dose conversion ratio of 4X\nSafe and well tolerated: XP-8121 in healthy volunteers was generally well tolerated at all doses\nNext Steps: FDA End-of-Phase 1 meeting requested; interaction expected by year-end",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.945+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6bc7580-be94-465e-b935-eb94ff6bbd75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.44,
            "x": 0.045,
            "y": 0.13
          },
          "kind": "title",
          "text": "XP-8121 Highlights and Next Steps",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:12.945+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "962329c3-6287-4e87-bb1c-c341144f5290",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 10,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 10,
          "name": "Key Takeaways",
          "beatId": "66138fc9-0919-4404-8cc7-48babd267bd8",
          "matchId": "d365dc78-252a-43d6-8e78-bb6869820ad1",
          "beatType": null,
          "evidence": "The key takeaways slide summarizes the main points.",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": null,
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 10,
          "from": 5,
          "loop": {
            "name": "11_golden_circle",
            "slug": "11-golden-circle",
            "status": "active",
            "bestFor": "Visionary leadership, brand positioning, mission statements",
            "canonId": "019dd956-6a50-7202-882d-505fcb9922ed",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
            "description": "Invert the typical pitch by starting with why you exist, rather than what you do",
            "familyLabel": null
          },
          "matchId": "f2a7b48c-76f2-4134-b42d-4dd72dd13ce4",
          "evidence": "The appendix methodology and key takeaways slides present the golden circle.",
          "position": 1,
          "objective": "How does XeriSol™ Levothyroxine work and what are the benefits?",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:25:26.250383+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 11,
      "type": "setup",
      "function": "state_next_steps",
      "rawType": "closing_ask",
      "block": null,
      "metadata": {
        "slideType": "closing_ask",
        "slideTypeCanon": {
          "name": "Closing ask",
          "slug": "closing_ask",
          "status": "active",
          "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c",
          "version": 1,
          "description": null
        },
        "function": "state_next_steps",
        "functionCanon": {
          "name": "State next steps",
          "slug": "state_next_steps",
          "status": "active",
          "canonId": "019de52d-14ca-70ac-b534-971f458cdf29",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 4,
        "textChars": 70,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 12:21:13.673+00",
          "seconds": 2.523,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de073-e127-72a6-a95e-e417b3ed6013/11",
        "deck": "/decks/019de073-e127-72a6-a95e-e417b3ed6013",
        "deckAnchor": "/decks/019de073-e127-72a6-a95e-e417b3ed6013#slide-11",
        "deckJson": "/decks/019de073-e127-72a6-a95e-e417b3ed6013.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.08,
            "y": 0.95
          },
          "kind": "disclaimer",
          "text": "Copyright ©2017-2022 Xeris Biopharma Holdings. All rights reserved.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c36ef6a-2a37-4e46-91b1-9491960955f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.15,
            "x": 0.08,
            "y": 0.0083
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "046a8898-c1b1-47aa-a366-bc716000a2eb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 1,
            "w": 0.55,
            "x": 0.45,
            "y": 0
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "79e88815-34b5-43a7-ad22-0d94cbb4aa8d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.1,
            "x": 0.08,
            "y": 0.2
          },
          "kind": "title",
          "text": "Q&A",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 12:21:13.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1180f0f9-3ec3-4551-8d35-22cef81b2c2a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 4,
      "to": 4,
      "label": "Problem",
      "description": "The market sizing slide presents the problem and opportunity."
    },
    {
      "from": 5,
      "to": 6,
      "label": "Product",
      "description": "The appendix methodology slides describe the product and study design."
    },
    {
      "from": 7,
      "to": 8,
      "label": "Solution",
      "description": "The traction and appendix methodology slides present the solution and clinical results."
    },
    {
      "from": 10,
      "to": 10,
      "label": "Key Takeaways",
      "description": "The key takeaways slide summarizes the main points."
    }
  ],
  "loops": [
    {
      "from": 4,
      "to": 4,
      "label": "Cost Of Inaction",
      "description": "What are the limitations of current Levothyroxine therapies?"
    },
    {
      "from": 5,
      "to": 10,
      "label": "Golden Circle",
      "description": "How does XeriSol™ Levothyroxine work and what are the benefits?"
    }
  ]
}